ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,422.45
-0.21%
Dow Jones
38,552.11
-0.25%
US Dollar vs MXN
18.4584
0.19%
Brent Oil
82.475
0.61%
Bitcoin
65,998.37
-1.14%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cumberland Pharmaceutical Inc (CPIX)

  7. Cumberland Pharmaceutical Inc (CPIX) Noticias

CPIX Cumberland Pharmaceutical Inc

1.57
0.02 (1.29%)
Última actualización: 09:14:18
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cumberland Pharmaceutical Inc CPIX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.02 1.29% 1.57 09:14:18
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.57 1.57 1.57 1.55
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/5/202415:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202416:14EDGAR2Form 8-K - Current report
07/5/202415:05PRNUSCumberland Pharmaceuticals Reports First Quarter 2024..
30/4/202415:05PRNUSCUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024..
02/4/202415:05PRNUSNEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE..
05/3/202416:10EDGAR2Form 8-K - Current report
05/3/202415:05PRNUSCumberland Pharmaceuticals Reports Annual 2023 Financial..
27/2/202415:05PRNUSCUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL..
09/2/202416:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/12/202316:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202316:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
15/12/202315:14EDGAR2Form DEL AM - Delaying amendment
14/12/202316:09EDGAR2Form S-3 - Registration statement under Securities Act of..
06/12/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202316:21EDGAR2Form 8-K - Current report
07/11/202315:05PRNUSCumberland Pharmaceuticals Reports Third Quarter 2023..
03/11/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202315:05PRNUSCUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023..
17/10/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202308:11EDGAR2Form 8-K - Current report
10/10/202315:05PRNUSNEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN..
03/10/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202309:55DJNCorrection to SEC Fines Article
27/9/202309:43DJNSEC Fines 5 Public Companies, Insiders Over Reporting..
19/9/202308:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202316:23EDGAR2Form 8-K - Current report
08/8/202315:05PRNUSCumberland Pharmaceuticals Reports Revenue and Earnings..
01/8/202315:05PRNUSCUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023..
30/6/202316:20EDGAR2Form 8-K - Current report
26/6/202308:00PRNUSNEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN..

Su Consulta Reciente

NASDAQ
CPIX
Cumberland Pharmaceutical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados